CLAIR HEALTH / THE TIMELINE
Clair can rewrite its website. It cannot rewrite the saved record of its claims, study plans and shipping targets.
THE SHIPPING PROMISES / RECORD CHECKED OCTOBER 16
Clair’s advertised shipping window moves later. The old promises stay on this page. Each entry shows the target and when it was recorded.
Reported shipping plan
Reported June 17, 2026
“ship units in November”Open source (opens in a new tab)
Founding Member shipping
Screenshot filename: October 8, 2026
“Founding Members ship December 2026.”Open source (opens in a new tab)
Current advertised shipping
Observed October 16, 2026
“Devices ship Jan 2027.”Open source (opens in a new tab)
The documented fact is a moving advertised target. As of October 16, all three shipping months are still ahead. These records do not establish three missed deadlines or identify which existing orders, if any, were moved.
THE COMPANY’S OWN WEBSITE
The supplied screenshot is named October 8 and promises December. The homepage retrieved on October 16 advertises January 2027. The wording changed. The filename does not establish when December first appeared, and the first appearance of January is also unknown.
Clair owes customers an explanation: why the advertised window changed, which orders were affected and what earlier buyers were promised. Editing the reserve button does not answer any of those questions.
Inspect the preserved shipping record →
The deck says “ahead of our November launch”; its B2B slide says “Shipping late 2026.” Launch and shipping are different milestones. Neither wording supplies a precise delivery date.
The March 12 Bizwomen profile gives a Q3 target: “planned formal launch in the third quarter.” February 16 Wareable coverage had already named November for the hardware. The public accounts conflict. That inconsistency deserves an answer, but it does not establish another chronological postponement.
The April and May dates in the archived science materials concern research studies. They are not product shipping deadlines.
More than 40 participants. 127 cycles. 94.10% phase accuracy. These are Clair’s figures in its archived essay, which calls the work a proof of concept and says the hardware has since evolved. The headline number does not validate the production device.
The dated science FAQ describes internal validation and numerical hormone estimates. It also lays out a staged product roadmap and future independent studies. The promises are there. Independent results are still a future step in that account.
April data-collection enrollment. A May independent-study start. Those are the plans in the archived documents. The documents record the schedule, not completed studies.
The redacted slides put the sales pitch on the public record: continuous hormone readings, app readouts, preorder figures, device-purchase MOUs and partner LOIs. Read the labels. The blacked-out details remain unknown.
Mayo Clinic names Clair among participants in its multiyear accelerator pathway. That confirms entry into a program. It supplies no completed validation of the bracelet.
The saved FAQ carries an October 8 print timestamp. The investigator reports a website refresh that evening. The old claims are preserved; the timestamp alone cannot establish exactly when they were removed.
The preserved homepage screenshot advertises December 2026 shipping for Founding Members. The October 8 date comes from the supplied filename. It does not establish when Clair first put that promise on its website.
Ryan Kern’s public LinkedIn post challenges the characterization of Clair’s B2B agreements. His letter-of-intent allegation and the accelerator profile’s contracts claim are separate items in the record. The post does not settle the underlying contract terms.
The current site sells hormone-aware health and claims training on clinical records. Production-hardware validation studies are described as launching. Put that wording beside the earlier validation claims.
Clair’s live homepage now names January 2027 for shipping. The wording and retrieval time are preserved beside the earlier December screenshot. Both targets are still in the future at this review date. The pages do not identify which earlier order batches, if any, moved.